A primary concern of surfactant‐assisted foams in enhanced oil recovery (EOR) is the stability of the foams. In recent studies, foam stability has been successfully improved by the use of nanoparticles (NP). The adhesion energy of the NP is larger than the adsorbed surfactant molecules at the air–water interface, leading to a steric barrier to mitigate foam‐film ruptures and liquid‐foam coalescence. In this study, the partially hydrophobic SiO2 nanoparticles (SiO2‐NP) were introduced to anionic mixed‐surfactant systems to investigate their potential for improving the foamability and stability. An appropriate ratio of internal olefin sulfonate (C15‐18 IOS) and sodium polyethylene glycol monohexadecyl ether sulfate (C32H66Na2O5S) was selected to avoid the formation of undesirable effects such as precipitation and phase separation under high‐salt conditions. The effects of the NP‐stabilized foams were investigated through a static foam column experiment. The surface tension, zeta potential, bubble size, and bubble size distribution were observed. The stability of the static foam in a column test was evaluated by co‐injecting the NP‐surfactant mixture with air gas. The results indicate that the foam stability depends on the dispersion of NP in the bulk phase and at the water–air interface. A correlation was observed in the NP‐stabilized foam that stability increased with increasing negative zeta potential values (−54.2 mv). This result also corresponds to the smallest bubble size (214 μm in diameter) and uniform size distribution pattern. The findings from this study provide insights into the viability of creating NP‐surfactant interactions in surfactant‐stabilized foams for oil field applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.